Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Viracta Therapeutics Inc
VIRXCurrent price
0.18 USD
+0.0005 USD (+0.28%)
Last closed
0.18 USD
Company
www.viracta.com
ISIN
US92765F1084
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 662 703 USD
Yield for 12 month
-68.88 %
1Y
3Y
5Y
10Y
15Y
VIRX
Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. The company's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Its product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California. Address: 2533 South Coast Highway 101, Cardiff, CA, United States, 92007
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-492 000 USD
Last Year
-210 000 USD
Current Quarter
-96 000 USD
Last Quarter
-110 000 USD
Key Figures VIRX
1 year
3 years
5 years
10 years
EBITDA
-49 044 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-57.2 %
PEG Ratio
–
Return On Equity TTM
-208.67 %
Wall Street Target Price
3.5 USD
Revenue TTM
–
Book Value
-0.071 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.16 USD
Diluted Eps TTM
-1.16 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VIRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VIRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
285:1000
Payout Ratio
–
Last Split Date
25.02.2021
Dividend Date
03.09.2020
Stock Valuation VIRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.4797
Price Book MRQ
3.4149
Financials VIRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VIRX
For 52 weeks
0.18 USD
1.31 USD
50 Day MA
0.23 USD
Shares Short Prior Month
1 326 060
200 Day MA
0.58 USD
Short Ratio
6.17
Shares Short
1 102 514
Short Percent
3.56 %
BeatStart